Literature DB >> 33642127

Neuroleptic malignant syndrome following COVID-19 vaccination.

Mostafa Alfishawy1, Zouheir Bitar2, Amr Elgazzar2, Mahmoud Elzoueiry2.   

Abstract

Entities:  

Year:  2021        PMID： 33642127     DOI： 10.1016/j.ajem.2021.02.011

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  2 in total

1.  Neuroleptic malignant syndrome associated with COVID-19 vaccination.

Authors:  Takahiko Nagamine
Journal:  CJEM       Date:  2021-12-17       Impact factor: 2.929

2.  Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report.

Authors:  Tomohito Mizuno; Riku Takahashi; Takahiro Kamiyama; Atsushi Suzuki; Masashi Suzuki
Journal:  Am J Case Rep       Date:  2022-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.